Notice2025-10234

Bulk Manufacturer of Controlled Substances Application: Usona Institute, Inc

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
June 5, 2025

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

Usona Institute, Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 107 (Thursday, June 5, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 107 (Thursday, June 5, 2025)]
[Notices]
[Page 23954]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-10234]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1552]


Bulk Manufacturer of Controlled Substances Application: Usona 
Institute, Inc

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Usona Institute, Inc has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on, or before 
August 4, 2025. Such persons may also file a written request for a 
hearing on the application on or before August 4, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on May 5, 2025, Usona Institute, Inc, 2780 Woods Hollow 
Road, Room 2413, Fitchburg, Wisconsin 53711, applied to be registered 
as a bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                            Drug
          Controlled substance              code          Schedule
------------------------------------------------------------------------
5-Methoxy-N-N-dimethyltryptamine........     7431  I
Psilocybin..............................     7437  I
Psilocyn................................     7438  I
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for use in chemical process development as well as pre-
clinical and clinical research. No other activities for these drug 
codes are authorized for this registration.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-10234 Filed 6-4-25; 8:45 am]
BILLING CODE P


</pre></body>
</html>
Indexed from Federal Register on June 5, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.